Balatian, Roseminda S.
HRN: 23-51-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2023
CEFTRIAXONE 1G (VIAL)
08/05/2023
08/11/2023
IV DRIP
2 G
OD
UTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes